OrbiMed Capital GP VI LLC, Director at Verona Pharma plc (VRNA), sold 8,994,928 shares at $22.07 ($200.7M) on 2022-12-22, disclosed to the SEC on 2022-12-27.
Open-market sale of $200.7M VRNA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.71 | 3,284,800 | $71.3M | 35.5% |
| 2 | $22.07 | 684,696 | $15.1M | 7.5% |
| 3 | $22.07 | 684,696 | $15.1M | 7.5% |
| 4 | $22.27 | 961,328 | $21.4M | 10.7% |
| 5 | $22.27 | 961,328 | $21.4M | 10.7% |
| 6 | $23.23 | 1,116,048 |
| $25.9M |
| 12.9% |
| 7 | $23.23 | 1,116,048 | $25.9M | 12.9% |
| 8 | $24.11 | 92,992 | $2.2M | 1.1% |
| 9 | $24.11 | 92,992 | $2.2M | 1.1% |
| Total | $22.31 avg | 8,994,928 | $200.7M | 100% |
| Filing → |
| IRON | SELL | 2025-03-12 | $32.4M | — | Filing → |
| SCPH | BUY | 2024-08-15 | $2.0M | — | Filing → |
| NPCE | SELL | 2024-04-18 | $435K | — | Filing → |